Inflexion, a leading European mid-market private equity firm, is pleased to announce the appointment of John DiGiovanni as Head of Healthcare, further strengthening the firm’s healthcare expertise. John will work closely with Andy Neville, Partner in the Healthcare team and interim head of Healthcare prior to John’s arrival.
John joins Inflexion with nearly two decades of global healthcare private equity experience. He most recently served as Healthcare sector co-leader, member of the Healthcare Investment Committee and Partner at Arsenal Capital Partners, a leading middle-market private equity firm with $10.8bn in AUM. During his tenure, he played a central role in building and leading one of the industry’s most active and successful healthcare investment platforms.
His direct transaction experience spans more than $2.5bn of enterprise value, including board roles across HCIT, technology-enabled healthcare services, and biopharma services.
Prior to Arsenal, John spent a decade at Baird Capital in the US and UK, where he helped shape the firm’s healthcare investment strategy, led cross-border deal sourcing efforts, and executed multiple successful transactions. He began his career in investment banking at Bank of America Merrill Lynch.
We are thrilled to welcome John to Inflexion. Healthcare is an important strategic priority for the firm, and his extensive sector knowledge, leadership experience, and outstanding track record of building and scaling healthcare businesses globally make him ideally suited to lead our efforts. John’s appointment reinforces our focus on partnering with ambitious and innovative healthcare companies.
Inflexion’s reputation is second to none and I am excited to join to lead the healthcare offering and work with the team to back exceptional businesses that are improving quality of care, enhancing clinical outcomes, and driving meaningful efficiency and innovation across the healthcare ecosystem.
Contact us
Please contact us if you have any media enquiries
